Clinical and epidemiological evidence indicate a relationship between thyroid diseases and melanoma. In particular, the hypothyroidism condition appears to promote melanoma spread, which suggests a protective role of thyroid hormones against disease progression. In addition, experimental data suggest that, in addition to thyroid hormones, other hormonal players of the hypothalamic-pituitary-thyroid (HPT) axis, namely the thyrotropin releasing hormone and the thyrotropin, are likely to affect melanoma cells behavior. This information warrants further clinical and experimental studies in order to build a precise pattern of action of the HPT hormones on melanoma cells. An improved knowledge of the involved molecular mechanism(s) could lead to a better and possibly personalized clinical management of these patients.
Is Melanoma Progression Affected by Thyroid Diseases? / Ulisse, Salvatore; Baldini, Enke; Pironi, Daniele; Gagliardi, Federica; Tripodi, Domenico; Lauro, Augusto; Carbotta, Sabino; Tarroni, Danilo; D'Armiento, Matteo; Morrone, Aldo; Forte, Flavio; Frattaroli, Flaminia; Persechino, Severino; Odorisio, Teresa; D'Andrea, Vito; Lori, Eleonora; Sorrenti, Salvatore. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1422-0067. - 23:17(2022). [10.3390/ijms231710036]
Is Melanoma Progression Affected by Thyroid Diseases?
Ulisse, Salvatore
;Baldini, Enke;Pironi, Daniele;Gagliardi, Federica;Tripodi, Domenico;Lauro, Augusto;Carbotta, Sabino;Tarroni, Danilo;Morrone, Aldo;Frattaroli, Flaminia;Persechino, Severino;D'Andrea, Vito;Lori, Eleonora;Sorrenti, Salvatore
2022
Abstract
Clinical and epidemiological evidence indicate a relationship between thyroid diseases and melanoma. In particular, the hypothyroidism condition appears to promote melanoma spread, which suggests a protective role of thyroid hormones against disease progression. In addition, experimental data suggest that, in addition to thyroid hormones, other hormonal players of the hypothalamic-pituitary-thyroid (HPT) axis, namely the thyrotropin releasing hormone and the thyrotropin, are likely to affect melanoma cells behavior. This information warrants further clinical and experimental studies in order to build a precise pattern of action of the HPT hormones on melanoma cells. An improved knowledge of the involved molecular mechanism(s) could lead to a better and possibly personalized clinical management of these patients.File | Dimensione | Formato | |
---|---|---|---|
Ulisse_Is-Melanoma-Progression_2022.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
562.84 kB
Formato
Adobe PDF
|
562.84 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.